Estradiol induces functional inactivation of p53 by intracellular redistribution

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2594-2597

  Molinari, Anna Maria ^a   Bontempo, Paola ^a   Schiavone, Ettore M ^a   Tortora, Vincenzo ^a   Verdicchio, M Antonietta ^a   Napolitano, Massimo ^a   Nola, Ernesto ^a   Moncharmont, Bruno ^a   Medici, Nicola ^a   Nigro, Vincenzo ^a   Armetta, Ignazio ^a   Abbondanza, Ciro ^a   Puca, Giovanni A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CELL GROWTH; CELLULAR DISTRIBUTION; DNA DAMAGE; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NEOPLASM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; S PHASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034657403     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Maltzman, W., and Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4: 1689-1694, 1984.
2. Woo, R. A., McLure, K. G., Lees-Miller, S. P., Rancourt, D. E., and Lee, P. W. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature (Lond.), 394: 700-704, 1998.
3. Waterman, M. J., Stavridi, E. S., Waterman, J. L., and Halazonetis, T. D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet., 19: 175-178 1998.
4. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (Washington DC), 281: 1677-1679, 1998.
5. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75: 817-825, 1993.
6. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunketl, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangieclasia. Cell, 71: 587-597, 1992.
7. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
8. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7: 1126-1132, 1993.
9. Barak, Y., Juven, T., Haffner, R., and Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J., 12: 461-468, 1993.
10. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237-1345, 1992.
11. Freedman, D. A., and Levine, A. J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol., 18: 7288-7293, 1998.
12. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
13. Lippman, M., Bolan, G., and Huff, K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res., 36: 4595-4601, 1976.
14. Runnebaum, I. B., Nagarajan, M., Bowman, M., Soto, D., and Sukumar, S. Mutations in p53 as potential molecular markers for human breast cancer. Proc. Natl. Acad. Sci. USA, 88: 10657-10661, 1991.
15. David-Pfeuty, T., Chakrani, F., Ory, K., and Nouvian-Dooghe, Y. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells. Cell. Growth Differ., 7: 1211-1225, 1996.
16. McKeehan, W. L., McKeehan, K. A., Hammond, S. L., and Ham, R. G. Improved medium for clonal growth of human diploid fibroblasts at low concentrations of serum protein. In Vitro, 13: 399-416, 1977.
17. Medici, N., Nigro, V., Abbondanza, C., Moncharmont, B., Molinari, A. M., and Puca, G. A. In vitro binding of the purified hormone-binding subunit of the estrogen receptor to oligonucleotides containing natural or modified sequences of an estrogen responsive element. Mol. Endocrinol., 5: 555-563, 1991.
18. Sheikh, M. S., Shao, Z. M., Hussain, A., and Fontana, J. A. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res., 53: 3226-3228, 1993.
19. Jayaraman, J., and Prives, C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell, 81: 1021-1029, 1995.
20. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14: 1815-1823, 1994.
21. Stommel, J. M., Marchenko, N. D., Jimenez, G. S. Moll, U. M., Hope, T., J., and Wahl, G. M. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J., 18: 1660-1672, 1999.
22. Moll, U. M., Riou, G., and Levine, A. J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA, 89: 7262-7266, 1992.
23. Foster, J. S., and Wimalasena, J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol., 10: 488-498, 1996.
24. Hurd, C., Khattree, N., Alban, P., Nag, K., Jhanwar, S. C., Dinda, S., and Moudgil, V. K. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. J. Biol. Chem., 270: 28507-28510, 1995.
25. Hurd, C., Khattree, N., Dinda, S., Alban, P., and Moudgil, V. K. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Oncogene, 15: 991-995, 1997.